Spectral transmittance of UV-blocking soft contact lenses: A comparative study

2014 ◽  
Vol 37 (6) ◽  
pp. 451-454 ◽  
Author(s):  
Saeed Rahmani ◽  
Mohadeseh Mohammadi Nia ◽  
Alireza Akbarzadeh Baghban ◽  
Mohammad Reza Nazari ◽  
Mohammad Ghassemi-Broumand
Nanomedicine ◽  
2016 ◽  
Vol 11 (12) ◽  
pp. 1599-1610 ◽  
Author(s):  
Y Shona Pek ◽  
Hong Wu ◽  
Edwin PY Chow ◽  
Jackie Y Ying

2001 ◽  
Vol 78 (SUPPLEMENT) ◽  
pp. 124
Author(s):  
Arthur Ho ◽  
Valerian Kuznetsov ◽  
Minas Coroneo

2015 ◽  
Vol 10 (4) ◽  
pp. 441 ◽  
Author(s):  
Saeed Rahmani ◽  
MohadesehMohammadi Nia ◽  
AlirezaAkbarzadeh Baghban ◽  
Mohammadreza Nazari ◽  
Mohammad Ghassemi-Broum

2009 ◽  
Vol 21 (5) ◽  
pp. 46-50
Author(s):  
N. Pasechnikova ◽  
◽  
G. Drozhzhina ◽  
O. Ivanova ◽  
I. Nasinnik ◽  
...  

2016 ◽  
Vol 16 (3) ◽  
pp. 117-120 ◽  
Author(s):  
T.N. Safonova ◽  
◽  
I.A. Novikov ◽  
V.I. Boev ◽  
O.V. Gladkova ◽  
...  

2021 ◽  
pp. 548-554
Author(s):  
Nir Erdinest ◽  
Naomi London ◽  
Nadav Levinger ◽  
Yair Morad

The goal of this retrospective case series is to demonstrate the effectivity of combination low-dose atropine therapy with peripheral defocus, double concentric circle design with a center distance soft contact lenses at controlling myopia progression over 1 year of treatment. Included in this series are 3 female children aged 8–10 years with progressing myopia averaging −4.37 ± 0.88 D at the beginning of treatment. Their average annual myopic progression during the 3 years prior to therapy was 1.12 ± 0.75 D. They had not attempted any myopia control treatments prior to this therapy. The children were treated with a combination of 0.01% atropine therapy with spherical peripheral defocus daily replacement soft lenses MiSight<sup>®</sup> 1 day (Cooper Vision, Phoenix, AZ, USA). They underwent cycloplegic refraction, and a slit-lamp evaluation every 6 months which confirmed no adverse reactions or staining was present. Each of the 3 children exhibited an average of 0.25 ± 0.25 D of myopia progression at the end of 1 year of treatment. To the best of the authors’ knowledge, this is the first published study exhibiting that combining low-dose atropine and peripheral defocus soft contact lenses is effective at controlling children’s moderate to severe myopia progression during 1 year of therapy.


Sign in / Sign up

Export Citation Format

Share Document